
SBI JI Innovation Advisory
SBI JI Innovation Advisory is a venture capital firm investing in Israeli biopharma and high-tech companies across various development stages.
About
Formed in 2017 as a partnership between SBI Holdings of Japan and Vertex Israel, SBI JI Innovation Advisory initially focused on bio-investments. Having successfully closed the investment period of its bio fund, the firm is expanding its interests to new sectors and territories, collaborating in Israel and surrounding countries. They cherry-pick Israeli or Israel-related venture-backed biopharma and high-tech companies across different development stages.
Key facts
At-a-glance profile data
- Website
- sbi-ji.co.il
- Type
- VC
- Headquarters
- Tel Aviv-Yafo, Israel
- Portfolio companies
- 12
- Stages
- SeedSeries ASeries BSeries CSeries D
- Cheque size
- $5M to $80M
- Sector focus
- HealthcareImmunologyImmunotherapyAlzheimersNeurology
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 7 Oct 2025 | Adicet Bio | Registered Direct Offering | $80M |
| 30 Oct 2024 | Secret Double Octopus | Series C | Undisclosed |
| 25 Jan 2024 | Adicet Bio | Follow-on Offering | $98M |
| 31 Jul 2023 | eToro | Secondary Transaction | $120M |
| 22 Mar 2023 | 431010 | Advanced Investment Agreement (AIA) | $250M |
| 25 Oct 2022 | Trigo | Funding Round | $100M |
| 15 Dec 2021 | Cylus | Series B | $30M |
| 16 Jun 2021 | Trigo | Series B | $10M |
| 1 Jun 2021 | Chemomab | Series C | $60M |
| 19 Feb 2021 | Ayala Pharmaceuticals | Series C | $25M |
Add first review
Frequently asked
What companies has SBI JI Innovation Advisory invested in?
SBI JI Innovation Advisory has invested in Adicet Bio, Secret Double Octopus, eToro, 431010, Trigo and 7 more.